<DOC>
	<DOC>NCT00694044</DOC>
	<brief_summary>1. Characterize the tolerability and safety of repeated doses of varenicline in healthy non-smoking elderly subjects. 2. Describe the steady state pharmacokinetics of varenicline in healthy non-smoking elderly subjects. 3. Evaluate the potential effects of repeat doses of varenicline on cognition in healtly non-smoking elderly subjects.</brief_summary>
	<brief_title>Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Healthy, Elderly (6585 years inclusive), Nonsmoker Creatinine Clearnace &lt; 30 ml/min, Evidence or history of clinically significant, unstable diseases</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Safety, Tolerability, Pharmacokinetics, Cognition</keyword>
</DOC>